G
Guillermo Torre-Amione
Researcher at Baylor College of Medicine
Publications - 121
Citations - 8177
Guillermo Torre-Amione is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Heart failure & Transplantation. The author has an hindex of 41, co-authored 110 publications receiving 7843 citations. Previous affiliations of Guillermo Torre-Amione include Houston Methodist Hospital.
Papers
More filters
Journal ArticleDOI
New therapeutics for chronic heart failure.
TL;DR: The rationale for existing heart failure therapies is reviewed and the reasoning behind the development of some emerging therapies is discussed, in which heart failure progresses because of the toxic effects of endogenous biological systems that become activated in heart failure.
Journal ArticleDOI
Decreased Expression of Tumor Necrosis Factor-α and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy
Sherif F. Nagueh,Sonny J. Stetson,Nasser Lakkis,Donna Killip,Alex Perez-Verdia,Mark L. Entman,William H. Spencer,Guillermo Torre-Amione +7 more
TL;DR: The initial experimental evidence is provided to suggest that TNF-&agr; may play a pathogenetic role in the hypertrophy of pressure overload in HOCM patients.
Journal ArticleDOI
The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content
Brian A. Bruckner,Sonny J. Stetson,John A. Farmer,Branislav Radovancevic,O.H. Frazier,George P. Noon,Mark L. Entman,Guillermo Torre-Amione,Keith A. Youker +8 more
TL;DR: It is demonstrated that chronic mechanical circulatory support significantly reduces fibrosis in the failing myocardium and regional collagen expression of an explanted heart.
Journal ArticleDOI
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure
Gad Cotter,Edo Kaluski,Karl Stangl,Richard Pacher,Christoph Richter,Olga Milo-Cotter,Loïc Perchenet,Isaac Kobrin,Shoshana Kaplan,Maurizio Rainisio,Aline Frey,Eric Neuhart,Zvi Vered,J. Dingemanse,Guillermo Torre-Amione +14 more
TL;DR: In previous studies, tezosentan, an intravenous (i.v.)‐balanced dual endothelin (ET‐A/B) antagonist, in doses of 50 and 100 mg/h, improved the hemodynamics but not the clinical outcome of patients with acute heart failure (AHF).
Journal ArticleDOI
Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor-α
Sonny J. Stetson,Alex Perez-Verdia,Wojceich Mazur,John A. Farmer,Michael M. Koerner,Donald G. Weilbaecher,Mark L. Entman,Miguel A. Quinones,George P. Noon,Guillermo Torre-Amione +9 more
TL;DR: It is suggested that the contribution of hypertension to cardiac allograft hypertrophy is minimal and that persistent intracardiac expression of TNF-α may contribute to the development of cardiacAllografthypertrophy.